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RESEARCH
Ultraviolet germicidal irradiation:
Possible method for respirator
disinfection to facilitate reuse
during the COVID-19 pandemic
To the Editor: The ability to disinfect and reuse
disposable N95 filtering facepiece respirators is
urgently needed during the current COVID-19
pandemic because supplies are running low in
hospitals throughout the United States and abroad.
Ultraviolet (UV) germicidal irradiation (UVGI) is one
possible method for respirator disinfection to
facilitate the reuse of dwindling supplies.
Dermatology offices often use narrow-band UVB to
treat skin diseases. If necessary, we propose a
possible repurposing of phototherapy devices,
including these UVB units, to serve as a platform
for UVC germicidal disinfection.
UVGI is a disinfection method that uses UVC
radiation to inactivate microorganisms by causing
DNA damage and preventing replication. Previous
studies have shown that UVC can inactivate
coronaviruses, including severe acute respiratory
syndrome coronavirus (SARS-CoV) and Middle
East respiratory syndrome coronavirus (MERSCoV).1 One study of respirators contaminated
with H1N1 influenza A found significant reductions ($3-log reduction) in viable influenza virus
under substantial artificial soiling conditions after
being treated for 60 to 70 seconds at an irradiance
of 17 mW/cm2, resulting in a UVGI dose of
;1 J/cm2 measured at 254 nm.2 The efficacy of
this dose has been verified in additional studies,
and higher doses (up to 2 J/cm2) have been shown
to provide diminished benefit after 1 J/cm2.3,4 It is
recommended to treat used masks, but not visibly
soiled, to allow the 3-log reduction reported in the
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literature to be sufficient to achieve safe reuse
levels.5
It is important to note that the time to deliver
1 J/cm2 depends on the irradiance; hence, it can
be longer or shorter depending on the delivery
device’s capabilities. In a prototype model that
has been developed (Fig 1), this dose can be
delivered in 1 minute and 40 seconds at an
irradiance of 10 mW/cm2. The distance from the
lamp to the top of the table in Fig 1 is approximately 14 cm.
However, UV radiation does degrade polymers,
which presents the possibility that UVGI exposure,
while decontaminating, may also reduce the efficacy
of the respirator and decrease protection to workers.
Lindsley et al6 exposed 4 different models of N95
filtering facepiece respirators to UVGI doses of 120 to
950 J/cm2. Results of the study showed that UVGI
exposure led to a small increase in particle penetration (up to 1.25%) and had little effect on the flow
resistance. However, at higher UVGI doses, the
strength of the layers of the respirator material was
substantially reduced (in some cases,[90%), but this
significantly varied among the different models.
UVGI had less of an effect on the respirator straps:
a dose of 2360 J/cm2 reduced the breaking strength
of the straps by 20% to 51%.6 It should be noted
that the dosages used in the study above are 100- to
1000-times higher than those shown to disinfect
H1N1 influenza Aecontaminated respirators.
Therefore, considering that many of our health care
providers are using substitutes for N95 filtering
facepiece respirators that offer very limited degree
of protection, using UVGI and repurposing phototherapy devices could be the best practical solution
at this time.

Fig 1. Image of prototype being developed by Daavlin. The field of irradiation is
approximately 15 inches 3 45 inches, and depending on the manufacturer of the mask, this
would allow for the treatment of ;18 to 27 masks (2 minutes per side). (A) With ultraviolet light
on and (B) ultraviolet light off. (Photographs used with permission of Bob Golding, Daavlin,
Byron, Ohio.)
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We would like to thank Bob Golding and his team at
Daavlin (Byron, OH) for leading the reengineering of a
phototherapy device that can be used to disinfect N95
masks.

Iltefat H. Hamzavi, MD,a Alexis B. Lyons, MD,a
Indermeet Kohli, PhD,a,b Shanthi Narla, MD,a
Angela Parks-Miller, CCRP, CWCA,a Joel M.
Gelfand, MD, MSCE,c Henry W. Lim, MD,a and
David M. Ozog, MDa
From the Department of Dermatology, Henry Ford
Hospital, Detroit, Michigana; the Department of
Physics & Astronomy, Wayne State University,
Detroit, Michiganb; and the Department of
Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia,
Pennsylvania.c
Funding sources: None.
Conflicts of interest: Drs Lyons and Narla are
subinvestigators and Dr Ozog is an investigator
for Biofrontera. Dr Lim has participated as a
speaker in general educational sessions for Ra
Medical System. Drs Hamzavi and Lim are
investigators and Dr Gelfand is principal investigator for the Light Treatment Effectiveness
(LITE) study, which is funded by the PatientCentered Outcomes Research Institute and for
which the home phototherapy machines are
provided by Daavlin. Dr Kohli and Ms ParksMiller have no relevant conflicts of interest to
report.
IRB approval status: Not applicable.
Additional supplemental material will be available
on Mendeley after publication.
Reprints not available from the authors.
Correspondence to: Iltefat H. Hamzavi, MD,
Department of Dermatology, Henry Ford Medical
Center New Center One, 3031 W Grand Blvd, Ste
800, Detroit, MI 48202
E-mail: ihamzav1@hfhs.org
REFERENCES
1. Bedell K, Buchaklian AH, Perlman S. Efficacy of an automated
multiple emitter whole-room ultraviolet-C disinfection system
against coronaviruses MHV and MERS-CoV. Infect Control Hosp
Epidemiol. 2016;37:598-599.
2. Mills D, Harnish DA, Lawrence C, Sandoval-Powers M,
Heimbuch BK. Ultraviolet germicidal irradiation of
influenza-contaminated N95 filtering facepiece respirators.
Am J Infect Control. 2018;46:e49-e55.
3. Fisher EM, Shaffer RE. A method to determine the available
UV-C dose for the decontamination of filtering facepiece
respirators. J Appl Microbiol. 2011;110:287-295.

J AM ACAD DERMATOL

JUNE 2020

4. Mills DS, Lawrence C, Heimbuch B, Harnish DA. Ultraviolet
Germicidal Irradiation of Influenza-Contaminated N95 Filtering
Facepiece Respirators. Poster presentation at: American Society for Microbiology. Poster Presentation. Available at: https://
www.fda.gov/downloads/EmergencyPreparedness/Counterter
rorism/MedicalCountermeasures/MCMRegulatoryScience/UC
M505730.pdf; 2016. Accessed March 23, 2020.
5. Eickmann M, Gravemann U, Handke W, et al. Inactivation of
three emerging viruses - severe acute respiratory syndrome
coronavirus, Crimean-Congo haemorrhagic fever virus and
Nipah virus - in platelet concentrates by ultraviolet C light and
in plasma by methylene blue plus visible light. Vox Sang. 2020.
https://doi.org/10.1111/vox.12888.
6. Lindsley WG, Martin SB Jr, Thewlis RE, et al. Effects of
ultraviolet germicidal irradiation (UVGI) on N95 respirator
filtration performance and structural integrity. J Occup Environ
Hyg. 2015;12:509-517.
https://doi.org/10.1016/j.jaad.2020.03.085

Intralesional Candida antigen
versus intralesional tuberculin in
the treatment of recalcitrant genital
warts: A comparative study
To the Editor: Despite the existence of numerous
therapeutic modalities, the treatment of genital warts
is still largely unsatisfactory. Intralesional antigen
immunotherapy has been investigated for genital
warts in a few studies enrolling small numbers of
patients and has shown promising efficacy, safety,
and low recurrence rates compared with traditional
ablative therapies.1-3
The study included 64 adult patients with multiple
recalcitrant genital warts, defined as warts that
persisted for more than 2 years and showed a failure
of response to at least 2 different modalities. Patients
were randomly assigned by flipping a coin to 2
groups, each containing 32 patients. A written
informed consent was taken from each patient
before enrollment into the study that was approved
by the Zagazig University Institutional Review Board.
The largest wart was directly injected, without
presensitization, with intralesional tuberculin or
Candida antigen (1/1000) at a dose of 0.1 mL at 2week intervals until complete clearance or for a
maximum of 5 sessions. Response to treatment was
evaluated by decrease in the size of the warts and
photographic comparison at baseline and at each
visit. The results were assessed by 2 blinded dermatologists (Supplemental Methods, available at
Mendeley, doi: 10.17632/w46xsffbp9.1).
There were 57 patients (8 men, 49 women) who
completed the study, and 7 patients discontinued
due to failure to follow-up (n ¼ 2), lack of response
(n ¼ 2), and adverse effects (n ¼ 3). Details of the
baseline characteristics of the studied patients are
presented in Table I.
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